FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmacology and medicine, and concerns a complex of trioxopyrimidine-cyclodextrin formed of a trioxopyrimidine derivative or salt and a water-soluble cyclodextrin derivative exhibiting improved solubility.
EFFECT: developing a pharmaceutical composition which is a matrix metalloprotease inhibitor.
10 cl, 16 dwg, 9 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF TRIOXOPYRIMIDINE FOR TREATMENT AND PREVENTION OF INFLAMMATORY BRONCHIAL DISEASES | 2005 |
|
RU2402329C2 |
| AQUEOUS ORAL SOLUTIONS OF STEROID HORMONES AND HYDROXYPROPYL-BETA-CYCLODEXTRIN WITH OPTIMISED BIOAVAILABILITY | 2013 |
|
RU2662314C2 |
| COMPOSITIONS BASED ON CYCLODEXTRIN AND A BUDESONIDE DERIVATIVE AND METHODS FOR PRODUCTION THEREOF | 2015 |
|
RU2722414C2 |
| ESTRAMUSTINE COMPOSITIONS WITH IMPROVED PHARMACEUTICAL PROPERTIES | 1995 |
|
RU2179036C2 |
| INCLUSION COMPLEX OF DISULFIRAM AND CYCLODEXTRIN | 2015 |
|
RU2592625C1 |
| SOLID PHARMACEUTICAL PREPARATIONS CONTAINING PHYSICAL MIXTURE OF CYCLODEXTRIN SULFOALKYL ETHER AND THERAPEUTIC AGENT | 1998 |
|
RU2173172C2 |
| METHOD FOR PRODUCTION OF INCLUSION COMPLEXES OF DISULFIRAM WITH CYCLODEXTRIN | 2015 |
|
RU2580567C1 |
| WATER-SOLUBLE COMPLEX OF BETA-CYCLODEXTRINE-HISTOCHROME INITIATION, POSSESSING PROLONGED ANTIOXIDANT ACTION | 2013 |
|
RU2530886C1 |
| COMPOSITION OF CLOPIDOGREL AND SULPHOALKYLESTER CYCLODEXTRIN (VERSIONS) AND METHODS OF TREATING DISEASES BY SAID COMPOSITION (VERSIONS) | 2008 |
|
RU2470636C2 |
| HEXAHYDROFURO[2,3-B]FURAN-3-YL-N-{3-[(1,3-BENZODIOXOL-5- YL- SULFONYL)(ISOBU TYL)AMINO]-1-BENZYL-2-HYDROXYPROPYL}CARBAMATE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHODS FOR INHIBITION AND METHOD FOR TREATMENT | 2000 |
|
RU2247123C2 |
